- Screening for ovarian carcinoma: not quite there yet - The Lancet Oncology, April 2009
- Major clinical research advances in gynecologic cancer - Journal Gynecol Oncol, Deccember 2008
- Cervical Cancer vaccine doesn't rule out the need for screening- WHU May 2007
- HRT & lung cancer survival - WHW June 2006
- NZ Govt Health Strategies - Cancer Control
- Silent epidemics strike at heart of women's health - WHU Jan 2004
- Cancer Control Strategy launched - October 2003
- HRT & Ovarian Cancer - WHW Sept 2002
- HRT & Gallbladder cancer - WHW Sept 2002
The new cervical cancer vaccine has taken the world by storm. Jesse Solomon looks at cervical cancer in New Zealand and the implications of the vaccine for New Zealand women. Cervical Screening has had a dramatic impact on the incidence of cervical cancer and cervical cancer mortality in developed countries including New Zealand. The New Zealand screening programme started in 1991 and now achieves around 75% coverage of eligible women. However, this is significantly lower amongst some groups including Maori women at 55%...
Cervical Screening is availible to all women in New Zealand and women can be screened by their GP, Family Planning or sexual health clinic. Cervical Cancer Screening is the single most effective intervention against cervical cancer...
A vaccine for some types of HPV has been approved for use in New Zealand...Concerns have been raised about some safety aspects of the vaccine, including the aluminium content and its long term neurological effects. The FDA in the United States have required Merck (the makers of Guardasil) to undertake further trials for safty amongst younger girls as the studies so far have not included many girls.... Read More
June 2006 Women's Health Watch
Further risks associated with hormone replacement therapy. A US study of 500 women with lung cancer found that women who had taken HRT had worse survival rates than women who had never taken HRT. The women with a history of HRT use (took HRT for at least 6 weeks) had an average survival rate of 39 months compared to 79 months for women with no HRT history. The differences in survival rates were even more pronounced for women who smoked and used HRT. The study concludes that this difference suggests a possible interaction between estrogens and the carcinogens present in cigarette smoke.
Ganti, A.P. et al. (2006) Hormone Replacement Therapy is associated with decreased survival in women with lung cancer. Journal of Clinical Oncology. Early online publication. November 28, 2005
January 2004 Women's Health Update
Gill Sanson recently attended a Green Party forum in Wellington hosted and organised by MP Sue Kedgeley on 'Silent Epidemics: Breast Cancer, Endometriosis and Chemical Sensitivity'. Gill reports on the blunt and troubling message delivered by the expert speakers.
Evidence is growing that New Zealand's relatively high levels of persistent organic pollutants (POPs) namely dioxins, PCBs, DDT, 24-D, DES, delivered to us via fuel emissions, incineration, household products, pesticides, cosmetics, glues, chemical sunscreens, plastic food containers and so on, are linked to endometriosis, breast and uterine cancers, heart disease, migraine, severe PMS, chronic fatigue syndrome, fibrocystic breast disease, fibroids and infertility.... Read More
The New Zealand Cancer Control Strategy was launched in August this year. The Cancer Control Strategy was the work of a partnership which included the Cancer Control Trust (a coalition of NGOs led by the Cancer Society of NZ and the Child Cancer Foundation) and government in the form of the Ministry of Health. In 2001 the Cancer Control Steering Group was formed to oversee the development of a Cancer Control Strategy and five working groups established priorities within defined areas and reported back to the Steering Group. After public consultation involving forums and written submissions the Cancer Control Strategy was launched. The strategy aims to reduce the incidence and impact of cancer and address the inequalities that emerge in relation to it.
There are six goals which each have a defined set of objectives. Each of the 25 objectives defines broad areas of action in relation to moving towards the goals.... Read More
September 2002 Women's Health Watch
In the same issue of JAMA that reported on the WHI study, researchers reported that women using oestrogen-only HRT had an increased risk of ovarian cancer, particularly if it was used for 10 or more years. In women who used it for 10 or more years the risk of developing ovarian cancer increased by 50% from 4 per 10,000 in women not using HRT to 6 per 10,000 women taking oestrogen.
September 2002 Women's Health Watch
An Italian case-control study has found the first direct epidemiological evidence of an association between hormone replacement therapy (HRT) in menopause and an increased risk of gallbladder cancer. Subjects included 31 women between 45 and 79 with gallbladder cancer and 3,702 age-matched controls. The odds ratio for gallbladder cancer was 3.2 for women who had ever used HRT, and it tended to increase with longer use
Next page: Cervical Cancer